Valuation Scienture Holdings, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 16/10/2026 BST			5-day change	1st Jan Change
3.360 ^USD	-0.59%		-10.64%	-73.65%

08-13	Scienture Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-12	Scienture Holdings Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy Nasal Spray 10 Mg	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	52.94	20.72	5.519	-	-
Change	-	-60.86%	-73.37%	-	-
Enterprise Value (EV)	52.94	20.72	5.519	5.519	5.519
Change	-	-60.86%	-73.37%	0%	0%
P/E	2.25x	-0.19x	-0.58x	-	0.61x
PBR	-	-	-	-	-
PEG	-	0x	0x	-	-
Capitalization / Revenue	-	48x	1.15x	0.32x	0.15x
EV / Revenue	-	0x	1.15x	0.32x	0.15x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-0x	-0.57x	12.4x	0.38x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	67.25	-67.5	-5.75	-	5.5
Distribution rate	-	-	-	-	-
Net sales ¹	-	0.4316	4.789	17.22	37.98
EBITDA	-	-	-	-	-
EBIT ¹	-	-42.59	-9.606	0.445	14.39
Net income ¹	9.066	-41.51	-9.622	0.135	11.26
Net Debt	-	-	-	-	-
Reference price ²	151.250	12.750	3.360	3.360	3.360
Nbr of stocks (in thousands)	350	1,625	1,643	-	-
Announcement Date	26/03/25	30/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCIENTURE HOLDINGS, INC.	-0.58x	-	-	-	5.52M
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	26.09x	6.95x	18.39x	2.15%	394.09B
Weighted average by Cap.	34.72x	8.20x	20.04x	1.84%